Stock Events

Enlivex Therapeutics (ENLV) Q3 2024 Earnings

30AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.39
-0.26
-0.13
0

Details

Expected EPS
-0.22
Actual EPS
-0.15
Surprise EPS
0.07
Surprise Percent
+31.82%

Description

Enlivex Therapeutics (ENLV) has reported earnings of -0.15 per share for Q3 2024.

0 Comments

Share your thoughts